Patents by Inventor Colin Lawrence

Colin Lawrence has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220340636
    Abstract: The present invention relates to insulin analogs, particularly insulin analogs having shortened B chains. The present invention also relates to the crystal structure of insulin from the venom of cone snails and to methods of using the crystal and related structural information to screen for and design insulin analogs that interact with or modulate the insulin receptor. The present invention also relates to therapeutic and prophylactic methods using insulin analogs.
    Type: Application
    Filed: January 4, 2022
    Publication date: October 27, 2022
    Inventors: John Gerbrandt Tasman MENTING, Brian SMITH, Danny Hung-Chieh CHOU, Helena SAFAVI-HEMAMI, Michael Colin LAWRENCE, Baldomero M. OLIVERA
  • Patent number: 11248034
    Abstract: The present invention relates to insulin analogs, particularly insulin analogs having shortened B chains. The present invention also relates to the crystal structure of insulin from the venom of cone snails and to methods of using the crystal and related structural information to screen for and design insulin analogs that interact with or modulate the insulin receptor. The present invention also relates to therapeutic and prophylactic methods using insulin analogs.
    Type: Grant
    Filed: July 21, 2017
    Date of Patent: February 15, 2022
    Assignees: University of Utah Research Foundation, The Walter and Eliza Hall Institute of Medical Research
    Inventors: John Gerbrandt Tasman Menting, Brian Smith, Danny Hung-Chieh Chou, Helena Safavi-Hemami, Michael Colin Lawrence, Baldomero M. Olivera
  • Publication number: 20190241640
    Abstract: The present invention relates to insulin analogs, particularly insulin analogs having shortened B chains. The present invention also relates to the crystal structure of insulin from the venom of cone snails and to methods of using the crystal and related structural information to screen for and design insulin analogs that interact with or modulate the insulin receptor. The present invention also relates to therapeutic and prophylactic methods using insulin analogs.
    Type: Application
    Filed: July 21, 2017
    Publication date: August 8, 2019
    Inventors: John Gerbrandt Tasman MENTING, Brian SMITH, Danny Hung-Chieh CHOU, Helena SAFAVI-HEMAMI, Michael Colin LAWRENCE, Olivera M. BALDOMERO
  • Publication number: 20150198619
    Abstract: The present invention relates to the crystal structure of the insulin receptor ectodomain in complex with human insulin and to methods of using the crystal and related structural information to identify, design and screen for compounds that interact with or modulate the insulin receptor and insulin receptor signalling.
    Type: Application
    Filed: September 18, 2013
    Publication date: July 16, 2015
    Inventors: Michael Colin Lawrence, John Gerbrandt Tasman Menting, Brian John Smith
  • Patent number: 8666718
    Abstract: The present invention relates generally to structural studies of the insulin binding site of the insulin receptor (IR) and the insulin-like growth factor 1 receptor (IGF-1R). More particularly, the present invention relates to the crystal structure of the low affinity insulin binding site of the IR ectodomain comprising the C-terminal region of the IR ?-chain, as well as the corresponding region of IGF-1R, and to methods of using the crystal and related structural information to screen for and design compounds that interact with or modulate the function of IR and/or IGF-1R.
    Type: Grant
    Filed: March 9, 2010
    Date of Patent: March 4, 2014
    Assignee: The Walter and Eliza Hall Institute of Medical Research
    Inventors: Michael Colin Lawrence, Brian John Smith, John Gerbrandt Tasman Menting, Colin Wesley Ward
  • Patent number: 8301398
    Abstract: The present invention relates to the crystal structure of the insulin receptor ectodomain, to the nature of its N-linked glycans and to methods of using the crystal and related structural information to screen for and design compounds that interact with or modulate the insulin receptor and/or the closely-related insulin-like growth factor receptors or variants thereof.
    Type: Grant
    Filed: June 22, 2007
    Date of Patent: October 30, 2012
    Assignee: Walter and Eliza Hall Institute of Medical Research
    Inventors: Thomas P. J. Garrett, Timothy Edward Adams, George Lovrecz, Neil Moreton McKern, Michael Colin Lawrence, Lindsay Gale Sparrow, Colin Wesley Ward, Meizhen Lou, Victor Strelstov
  • Publication number: 20120122771
    Abstract: The present invention relates generally to structural studies of the insulin binding site of the insulin receptor (IR) and the insulin-like growth factor 1 receptor (IGF-1R). More particularly, the present invention relates to the crystal structure of the low affinity insulin binding site of the IR ectodomain comprising the C-terminal region of the IR ?-chain, as well as the corresponding region of IGF-1R, and to methods of using the crystal and related structural information to screen for and design compounds that interact with or modulate the function of IR and/or IGF-1R.
    Type: Application
    Filed: March 9, 2010
    Publication date: May 17, 2012
    Inventors: Michael Colin Lawrence, Brian John Smith, John Gerbrandt Tasman Menting, Colin Wesley Ward
  • Publication number: 20100267927
    Abstract: The present invention relates to the crystal structure of the insulin receptor ectodomain, to the nature of its N-linked glycans and to methods of using the crystal and related structural information to screen for and design compounds that interact with or modulate the insulin receptor and/or the closely-related insulin-like growth factor receptors or variants thereof.
    Type: Application
    Filed: June 22, 2007
    Publication date: October 21, 2010
    Inventors: Thomas P.J. Garrett, Timothy Edward Admas, George Lovrecz, Neil Moreton McKern, Michael Colin Lawrence, Lindsay Gale Sparrow, Colin Wesley Ward, Meizhen Lou, Victor Strelstov
  • Publication number: 20100011960
    Abstract: The invention provides a filter for separating very small particles or organisms from the air or gas in which they are carried, comprising a filter mechanism and a duct, chamber or pipe to contain and transport the air or gas and to house the filter mechanism; the filter mechanism comprising: a particle charging means, a means to introduce charged or uncharged atomized droplets of liquids or reagents into the air or gas after the particle charging stage, and a capture means for collecting the atomized droplets and/or very small particles or organisms.
    Type: Application
    Filed: July 18, 2005
    Publication date: January 21, 2010
    Inventor: Colin Lawrence
  • Publication number: 20080187122
    Abstract: To provide a globally useful telephone number a character string which may be similar to an email address may be provided to a mobile phone server or an internet server for translation to the actual phone number and establishment of a call to that number.
    Type: Application
    Filed: January 17, 2006
    Publication date: August 7, 2008
    Inventor: Colin Lawrence Melvin Baker
  • Publication number: 20040237432
    Abstract: A foundation component (1) is disclosed which is suitable for forming part of a modular foundation for a building structure. The foundation component (1), defines at least one receptacle (2) which, in use, may be filled with a suitable particulate material. A plurality of protrusions (5) extending generally downwards from the base (6) of the foundation component (1) engage a foundation surface on which the foundation component is located. In a preferred embodiment the foundation component may include tongue in groove interengagement of adjacent foundation components (1), and may also include provision for service channels and reinforcing rods.
    Type: Application
    Filed: July 7, 2004
    Publication date: December 2, 2004
    Inventors: Colin Lawrence Melvin Baker, Bruce Philip West
  • Publication number: 20030018563
    Abstract: The present invention is a system and method combining financial product innovation, business process management, and proprietary software integration in a holistic fashion for the funding, trading, processing and management of commercial accounts receivable.
    Type: Application
    Filed: July 13, 2001
    Publication date: January 23, 2003
    Applicant: Efficient Capital Corporation
    Inventors: Colin Lawrence Kilgour, Andrew Kevin Dayes